| Page 1153 | Kisaco Research
 

Joseph Gridley

Chief Privacy Officer
University of Maryland

Joseph Gridley

Chief Privacy Officer
University of Maryland

Joseph Gridley

Chief Privacy Officer
University of Maryland
 

Jennifer Harkins Garone

Senior Director, Privacy and Information
Governance Carnival Corporation

Jennifer Harkins Garone

Senior Director, Privacy and Information
Governance Carnival Corporation

Jennifer Harkins Garone

Senior Director, Privacy and Information
Governance Carnival Corporation
2023 INVESTOR FORUM APPLICATION
2023 CEO & FOUNDERS FORUM APPLICATION
 

Bart Maene

Global Scientific Affairs
3M

Bart Maene

Global Scientific Affairs
3M

Bart Maene

Global Scientific Affairs
3M
 

Issy Gordon

Healthcare Associate
Hambro Perks

Issy Gordon

Healthcare Associate
Hambro Perks

Issy Gordon

Healthcare Associate
Hambro Perks
 

Heloïse Nogues

FemTech Lead Program Manager
Station F

Heloïse Nogues

FemTech Lead Program Manager
Station F

Heloïse Nogues

FemTech Lead Program Manager
Station F
 

Alia El-Yassir

Regional Director for Europe and Central Asia
UN Women

Alia El-Yassir

Regional Director for Europe and Central Asia
UN Women

Alia El-Yassir

Regional Director for Europe and Central Asia
UN Women
 

Robert G. Bristow

Director
Manchester Cancer Research Centre

Robert Bristow completed his PhD in Medical Biophysics and Residency in Radiation Oncology at the University of Toronto with post-graduate fellowships at Erasmus University Rotterdam, MD Anderson Cancer Centre and Massachusetts General Hospital.

Robert G. Bristow

Director
Manchester Cancer Research Centre

Robert G. Bristow

Director
Manchester Cancer Research Centre

Robert Bristow completed his PhD in Medical Biophysics and Residency in Radiation Oncology at the University of Toronto with post-graduate fellowships at Erasmus University Rotterdam, MD Anderson Cancer Centre and Massachusetts General Hospital.

Bristow joined the University of Manchester as Director of the Manchester Cancer Research Centre (MCRC) in August 2017 to develop a new cancer strategy. His research focusses on the prostate cancer genome and tumour microenvironment hypoxic tumour cell characterisation by understanding role of hypoxia in driving genetic instability and the changes in sporadic and hereditary (e.g. BRCA2) prostate cancer genomes during cancer aggression.

He co-Leads the Manchester arm of the International Alliance for Cancer Early Detection (ACED), with an interest in signatures that predict aggression in men with sporadic and hereditary prostate cancer. Rob also sits on the Alliance Executive Board (AEB).